The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPhysiomics Share News (PYC)

Share Price Information for Physiomics (PYC)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1.30
Bid: 1.20
Ask: 1.40
Change: -0.20 (-13.33%)
Spread: 0.20 (16.667%)
Open: 1.25
High: 1.30
Low: 1.05
Prev. Close: 1.50
PYC Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

AIM WINNERS & LOSERS: Corcel rises on "shovel ready" Tring Road stake

Mon, 10th May 2021 10:19

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Monday.

----------

AIM - WINNERS

----------

Corcel PLC, up 16% at 1.89 pence, 12-month range 0.7p-2.42p. Buys 40% stake in "shovel ready" Tring Road 50 megawatt gas peaking project outside of Aylesbury, England, from Arlington Energy Ltd. Purchase consideration is GBP400,000, to be satisfied by GBP150,000 in cash and 12.0 million new shares. "This is a highly significant milestone for Corcel. The addition of the 'shovel ready' Tring Road project to our existing Burwell project dramatically bolsters our position in the increasingly competitive flexible energy space here in the UK," says Chief Executive Scott Kaintz.

----------

Petro Matad, up 14% at 5.83p, 12-month range 2.16p-6.15p. Says Mineral Resources Professional Council will approve company's Heron field plan of development once certain technical clarifications have been provided and any resulting amendments to the documentation deemed necessary have been made. "With the recent relaxation of lockdown restrictions in Mongolia, the company is now in discussion with MRPC's designated officials to clarify the points raised in order to secure MRPC written approval of the Plan of Development," says Petro Matad.

----------

President Energy PLC, up 12% at 2.47p, 12-month range 1.1p-2.89p. The energy company says EV-1002, a new gas well as the Estancia Vieja field, has been successfully drilled, logged and cased on time and budget. Adds that LB-1002 well has now been placed on production and is performing better than pre-drilling expectations. Further, company says that average oil prices realised for first five months of 2021 are running 35% higher than for the full-year 2020. Gas prices also running higher.

----------

AIM - LOSERS

----------

Hurricane Energy PLC, down 9.7% at 0.7651p, 12-month range 0.72p-12.7p. The oil & gas company says average oil production rate for April at Lancaster field, located west of Shetland, Scotland, was lower than prior months. Output during April was 303,000 barrels from the P6 well and just 19,000 barrels from the 205/21a-7z well. This was lower than prior months, Hurricane Energy says, as the P6 well was producing on a standalone basis in line with the company's near-term production strategy. The P7z well produced for only nine days in the month for the purpose of well testing.

----------

Physiomics PLC, down 7.0% at 5.95p, 12-month range 3.55p-17.25p. Says results for current financial year to be below market expectations due to both pandemic-related project delays and an "increased focus on longer-term value-generating activities". Total income for year to June 30 to be in range of GBP700,000 to GBP800,000 and loss after tax around GBP170,000 to GBP200,000. "The pharmaceuticals and biotech industry has weathered the Covid storm better than many other sectors and industries, however it is not immune, and it is well known that trial delays have been a knock-on effect. We believe the impact on Physiomics will be temporary and we already see that clinical trials and patient recruitment are showing signs of returning to normality," says Chief Executive Jim Millen.

----------

By Lucy Heming; lucyheming@alliancenews.com

Copyright 2021 Alliance News Limited. All Rights Reserved.

More News
21 Jun 2018 09:17

Physiomics Expects Annual Loss To Be "Materially Reduced"

LONDON (Alliance News) - Physiomics PLC said Thursday it is trading "ahead of market expectations" for its financial year to the end of June.The company, which provides technology

Read more
23 May 2018 12:44

Physiomics Raises GBP525,000 Via Placing For Expansion (ALLISS)

LONDON (Alliance News) - Physiomics PLC on Wednesday said that it raised GBP525,000 through share placing to grow the business and expand its client base.The biotechnology company issued at

Read more
14 Mar 2018 12:42

Physiomics Awarded New GBP68,000 Innovate UK Grant For Cancer Project

LONDON (Alliance News) - Physiomics PLC said Wednesday it has been awarded a new Innovate UK Grant worth GBP68,000 for a prostate cancer -

Read more
12 Mar 2018 11:34

Physiomics Successfully Completes Innovate UK Grant Project

LONDON (Alliance News) - Physiomics PLC said Monday it has successfully completed the Innovate UK grant cancer treatment project, receiving in funding the

Read more
11 Jan 2017 14:22

Physiomics makes 'good progress' towards objectives

(ShareCast News) - Physiomics announced on Wednesday that it is making good progress towards the strategic objectives announced in its most recent full year results, posted on 27 October 2016. The AIM-traded firm announced an initial payment by Sareum on 5 December, for modelling carried out by the

Read more
6 Jan 2017 12:28

Physiomics receives Innovate UK grant for cancer treatment project

(ShareCast News) - Systems biology company Physiomics confirmed on Friday that is has been awarded the Innovate UK grant as part of its Biomedical Catalyst 2016 Feasibility Study Competition that was the subject of a provisional announcement on 22 November. The AIM-traded firm said the proposed proj

Read more
22 Nov 2016 10:57

Physiomics Provisionally Awarded Innovate UK Grant

Read more
27 Oct 2016 14:15

Physiomics Annual Loss Widens After Incurring Additional Costs

Read more
21 Sep 2016 10:43

Physiomics raises £555,000 after shelving BioMoti acquisition

(ShareCast News) - AIM listed Physiomics has called off its BioMoti acquisition after investors instead backed plans to develop its modelling and simulation business with a £555,000 discounted fundraising. Physiomics, which develops software to help drug companies predict and understand cancer drug

Read more
16 May 2016 07:26

Physiomics Signs Two Extensions On Virtual Tumour Project

Read more
3 May 2016 07:39

Physiomics Appoints Andrew Clayden As Part-Time Head Of Finance

Read more
18 Apr 2016 13:41

James Millen takes the helm at Physiomics

(ShareCast News) - Physiomics had a new man at the helm on Monday, confirming Dr James Millen was taking the reins as CEO with immediate effect. The AIM-traded company said Millen, known as Jim, brought experience of drug development and licensing deals in global pharmaceutical companies with him.

Read more
18 Apr 2016 08:51

Physiomics Names James Millen As Chief Executive

Read more
4 Apr 2016 11:24

Physiomics Inks Further Contract With Speciality Pharma Customer

Read more
31 Mar 2016 10:11

Physiomics To Buy BioMoti And Raise Funds As CEO Steps Down (ALLISS)

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.